Arkolith/Insider Trading/BOLT/Form 4

Quinn William P.

President, CEO and CFO, DirectorBolt Biotherapeutics, Inc. (BOLT) · full profile →Form 4 · filed May 5, 2025
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Buy(P)3K$0.50$1K41K
Jun 6, 2024Buy(P)3K$0.64$2K39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2025Grant(A)700K—$0700K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-063840) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Bolt Biotherapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp